Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results

Rhea-AI Summary

Eyenovia, Inc. (NASDAQ: EYEN), a clinical-stage ophthalmic biopharmaceutical firm, is set to release its financial results for Q1 2020 on May 13, 2020, post-market close. Dr. Sean Ianchulev, CEO, alongside CFO John Gandolfo and VP Michael Rowe, will conduct a conference call at 4:45 PM ET to discuss the results. The call can be accessed by dialing 1-866-916-2921 (US) or 1-210-874-7771 (International), using conference code 4397339. The event will also be streamed live on Eyenovia's investor relations webpage and archived for one year.

Positive

• Scheduled financial results release for Q1 2020 may improve transparency and investor confidence.
• Conference call allows for direct communication with management, potentially boosting shareholder engagement.

Negative

• None.

NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that the Company will release financial results for the first quarter ended March 31, 2020 on Wednesday, May 13, 2020, after the market closes. Following the release, Dr. Sean Ianchulev, Chief Executive Officer and Chief Medical Officer, John Gandolfo, Chief Financial Officer, and Michael Rowe, Vice President, Commercial will host a conference call to review the financial results.

The conference call is scheduled to begin at 4:45pm ET on Wednesday, May 13, 2020. Participants should dial 1-866-916-2921 (United States) or 1-210-874-7771 (International) with the conference code 4397339. A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at www.eyenovia.com.

After the live webcast, the event will be archived on Eyenovia’s website for one year. In addition, a telephonic replay of the call will be available until May 20, 2020. The replay can be accessed by dialing 1-855-859-2056 (United States) or 1-404-537-3406 (International) with confirmation code 4397339.

About Eyenovia
Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more Information please visit www.eyenovia.com.

Company Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenoviabio.com

Investor Contact:
The Ruth Group
Tram Bui / Alexander Lobo
Phone: 646-536-7035/7037
tbui@theruthgroup.com / alobo@theruthgroup.com

Media Contact:
The Ruth Group
Kirsten Thomas
Phone: 508-280-6592
kthomas@theruthgroup.com

FAQ

When will Eyenovia announce its Q1 2020 financial results?

Eyenovia will announce its Q1 2020 financial results on May 13, 2020, after market close.

What time is the Eyenovia conference call scheduled for?

The Eyenovia conference call is scheduled for May 13, 2020, at 4:45 PM ET.

How can I access the Eyenovia conference call?

You can access the Eyenovia conference call by dialing 1-866-916-2921 (US) or 1-210-874-7771 (International) with conference code 4397339.

Where can I find the archived Eyenovia conference call?

The archived conference call will be available on Eyenovia's investor relations page for one year following the event.